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Ceramidase hydrolyzes ceramide and produces sphingosine as a substrate of sphingosine kinase
(SPHK), which transforms sphingosine to sphingosine-1-phosphate. It has been reported that cyto-
kines elicit SPHK activation in rat b-cells. As a sphingosine provider, ceramidase should also be acti-
vated. In our previous work, we showed that the increase in mRNA and protein levels in cytokine-
treated INS-1 rat b-cells resulted in chronic activation of neutral ceramidase. Here we found that
acid ceramidase (AC) is activated by cytokines at an early stage via tyrosine phosphorylation. In
addition, basal AC activity was ﬁrst detected in INS-1 cells and isolated rat islets, and cytokine-
induced cell growth was signiﬁcantly repressed when AC was pharmacologically inhibited.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Type 1 diabetes mellitus is an autoimmune disease in which
insulin-producing b-cells of the Langerhans islets is selectively de-
stroyed [1]. Growing evidence reveals that inﬁltrated-immune
cells in and around pancreatic islets play a pivotal role in its early
pathogenesis [2]. Cytokines implicated in pancreatic islets autoim-
mune damage including interleukin (IL)-1b, tumor necrosis factor
(TNF)-a and interferon (IFN)-c inhibit b-cell metabolism leading
to apoptosis and participate in the initial destruction of b-cell lead-
ing to the development of diabetes [3,4]. However, the detailed
mechanism in cytokine-induced b-cell destruction remains un-
known. A previous report revealed that treatment of rat b-cells
and islets with cytokines induces an increase in sphingosine kinasechemical Societies. Published by E
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phosphate (S1P) [5]. The authors further conﬁrmed that this SPHK
activation appears to occur in at least two phases: an early phase
that is expected to be largely independent on new protein synthe-
sis and a late phase that is dependent on new protein synthesis [5].
Having in mind that sphingosine, a substrate of SPHK, is only pro-
duced by the action of ceramidases including acid, neutral and
alkaline ceramidase [6], ceramidase is crucial not only for ceramide
degradation, but also for sphingosine and/or S1P generation [6,7].
It has also been proposed that the concomitant activation of cer-
amidase and S1P generation occur in response to several stimuli,
including cytokine [8], oxLDL [9], advanced glycation end products
[10] and growth factors [11,12]. But whether ceramidase is acti-
vated in parallel to the biphasic regulation of SPHK in response
to cytokines in b-cells is still unknown. Lately, we reported that ba-
sal neutral ceramidase (NC) activity appeared in rat b-cells, and
cytokines treatment led to NC chronic activation (>8 h, late phase)
through NC mRNA and protein upregulation [13]. In this study, we
found that acid ceramidase (AC) plays a similar role at early stage
(within 4 h) under cytokines treatment in b-cells via tyrosine phos-
phorylation in AC. Interestingly, pharmacological inhibition of AC
potentiated cytokine-induced cell growth inhibition in b-cells.lsevier B.V. All rights reserved.
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2.1. Cell culture and reagents
The rat insulin-secreting INS-1 cells (a kind gift from Prof. Xiao
Han, Key Laboratory of Human Functional Genomics of Jiangsu
Province, Nanjing Medical University, Nanjing, China) were grown
in RPMI-1640 medium supplemented with 10 mM HEPES, 10% fe-
tal calf serum (FCS), 2 mM L-glutamine, 1 mM sodium pyruvate,
50 lM 2-mercaptoethanol, 100 U/ml penicillin, and 100 mg/l
streptomycin. The cells were cultured at 37 C in the presence of
5% CO2. Recombinant rat IL-1b, TNF-a, and IFN-c, collagenase type
V, protease inhibitor cocktail, o-phthaldehyde, genisten, thiazolyl
blue tetrazolium bromide (MTT), and anti-b actin mouse monoclo-
nal antibody were obtained from Sigma (St. Louis, MO, USA). Tri-
Pure isolation reagent was from Roche (Indianapolis, IN, USA).
The reverse transcriptase kit was purchased from Toyobo (Osaka,
Japan). A polyclonal goat antibody against rat AC was from Santa
Cruz Biotechnology (Santa Cruz, CA, USA). N-oleoylethanolamine
(NOE) was from CalBiochem-Merck (Darmstadt, Germany). C17-D-
erythro-sphingosine and C12-ceramide were purchased from Avan-
ti Polar Lipids (Alabaster, AL, USA). C12-D-erythro-sphingosine was
from Larodan (Malmö, Sweden). Horseradish peroxidase-conju-
gated anti-goat or anti-mouse immunoglobulins were purchased
from DakoCytomation (Glostrup, Denmark). Triton X-100 and the
bicinchoninic acid (BCA) protein assay kit were from Pierce (Rock-
ford, IL, USA).
2.2. Islets isolation and culture
Male Sprague–Dawley rats (250–300 g) were purchased from
Animal Facilities of Nanjing Medical University. Islets of Langer-
hans were isolated from rat as previously described with some
modiﬁcations [14]. Brieﬂy, the pancreas was perfused with 10 ml
of 0.5 mg/ml collagenase type V via the common bile duct, fol-
lowed by digestion in 5 ml of 0.5 mg/ml collagenase for 15–
20 min with gentle shaking at 37 C, and terminated by the addi-
tion of cold Hanks balanced salt solution containing 10% FCS. After
ﬁltrated through a mesh screen, the islets in the pellet were sepa-
rated by using a Histopaque-1077 gradient. The isolated islets were
handpicked under a microscope, and cultured in RPMI-1640 med-
ium supplemented with 10 mM HEPES, 10% FCS, 2 mM L-gluta-
mine, 1 mM sodium pyruvate, 100 U/ml penicillin, and 100 mg/l
streptomycin.
2.3. RNA isolation and semi-quantitative RT–PCR
After treatment with a cytokine mixture (5 ng/ml IL-1b, 10 ng/
ml TNF-a, and 50 ng/ml IFN-c) for the indicated time periods,
RNA was extracted from rat islets (300–500 islets per extract) or
from INS-1 cells, then extracted RNA was used to produce cDNA
as described before [13]. RT-PCR was done using speciﬁc primers
for rat AC, glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
and the sequences were as follows: AC forward 50-
GCCCAATGGGTAGGGTTTAT-30 and reverse 50-TGTCCTGTATGCTGG
CTGAT-30; GAPDH forward 50-CACCCTGTTGCTGTAGCCATATTC-30
and reverse 50-GACATCAAGAAGGTGGTGAAGCAG-30. PCR products
(479 bp for AC and 196 bp for GAPDH) were separated in a 2% aga-
rose gel.2.4. Western blotting analysis and immunoprecipitation
Cellular proteins were prepared from INS-1 cells or isolated is-
lets, and western blotting was performed. Brieﬂy, INS-1 cells or iso-
lated islets were collected and resuspended in buffer A (25 mMHEPES, pH 7.5, 5 mM EDTA, 0.5% Triton X-100, 1.5 mM sodium
ﬂuoride, 1 mM sodium vanadate, and 10 ll/ml protease inhibitor
mixture), then homogenized by brief sonication. The homogenate
was centrifuged for 10 min at 10 000g at 4 C, and the superna-
tant was taken for protein determination. The cellular proteins
were then electrophoresed in a 7.5% SDS–PAGE gel and transferred
onto Hybond ECL membrane (Amersham Biosciences, Piscataway,
NJ, USA). The membrane was incubated with primary antibody
against AC (1:500) at 4 C overnight, followed by incubation with
horseradish peroxidase-conjugated secondary antibody (1:2000)
for 2 h at room temperature. The signals were detected with the
ECL system. To control equal lane loading, the same membrane
was probed with anti-b-actin antibody (1:5000) after being
stripped with stripping solution. The signals were quantiﬁed by
scanning densitometry using National Institutes of Health Image
J software (NIH, Bethesda, MD, USA). For immunoprecipitation
experiment, AC was immuno-precipitated using AC antibody and
20 ll (50% slurry) protein G agarose. The precipitated proteins of
the whole cell lysate from INS-1 cells were washed three times
with lysis buffer and resuspended in SDS sample buffer. These
samples were then separated on 7.5% SDS–PAGE, transferred to
Hybond ECL membranes, probed with anti-phosphotyrosine
4G10 antibodies (Upstate Biotechnology, Lake Placid, NY, USA),
and the bands were visualized by ECL system.
2.5. MTT assay
INS-1 cells were seeded in 96-well tissue culture dishes (the cell
density is 5.0  104 cells per well) for 24 h, cells were then cultured
in medium without FCS supplement for 4 h, subsequently pre-
treated with NOE (100 lM) or not for 2 h, and followed by incuba-
tion with cytokines for further 18 h. Then the medium was
removed, 200 ll of MTT at ﬁnal concentration of 1.0 mg/ml was
added to the wells. After incubated for 3 h at 37 C in an atmo-
sphere containing 95% air and 5% CO2, the MTT solution was re-
moved, 100 ll dissolving solution (20% SDS-50% N,N-dimethyl-
formamide, PH 4.7) was added, and then the absorbance at
570 nm was measured with microplate reader.
2.6. AC activity assay
AC activity was determined by the released sphingoid base from
ceramide using a HPLC assay according to our previous method
[13,15]. Brieﬂy, INS-1 cells or isolated islets were collected and
resuspended in buffer A and homogenized by brief sonication.
After centrifuging for 15 min at 10 000g at 4 C, the supernatant
was collected, and the protein concentration was determined by
the BCA method. Each sample containing 100 lg of protein was
then assayed for AC activity by incubation with 100 lM C12-cera-
mide in 0.2 M sodium acetate buffer (pH 4.5) containing 0.2% Tri-
ton X-100 and 5 mM CaCl2 for 2 h at 37 C. The reactions were
stopped by extraction with chloroform and methanol. The o-phth-
aldehyde derivative of released sphingosine was determined by
HPLC with C12-D-erythro-sphingosine as an external standard and
C17-D-erythro-sphingosine as an internal standard. HPLC was con-
ducted using the Agilent 1050-HPLC model ﬁtted with an eclipse
XDB-C18 column (Agilent Technologies, Palo Alto, CA, USA). The
solvent was methanol-potassium phosphate buffer (90:10 v/v)
and the ﬂow rate was 0.7 ml/min. A HP1046 ﬂuorescence detector
with an excitation at 345 nm and emission at 455 nm was used.
2.7. Statistical analysis
Data expressed as the mean ± S.D. were analyzed by Student’s t-
test or ANOVA. A P value of <0.05 was considered as statistically
signiﬁcant.
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3.1. AC activation is induced by cytokines
To observe whether basal AC activity is present in INS-1 cells or
rat pancreatic islets and how AC activity is affected by cytokines,
INS-1 cells or isolated islets were treated for different time periods
with a mixture of cytokines (5 ng/ml IL-1b, 10 ng/ml TNF-a, and
50 ng/ml IFN-c) which was shown to cause signiﬁcant damage to
b-cells [16,17], then AC activity was measured by quantitating
the released sphingosine. The results showed that pancreatic b-
cells exhibited some basal AC activity (26.3 ± 3.9 pmol sphingo-
sine min1 mg1 protein in INS-1 cells and 15.5 ± 2.3 pmol sphin-
gosine min1 mg1 protein in isolated islets). Moreover, AC
activity in INS-1 cells was increased by cytokine treatment: it oc-
curred at 30 min (152.3 ± 19.0% of the control), peaked at 2 h
(173.5 ± 30.1% of the control), and decreased to the basic level at
8 h (Fig. 1A). Similarly, AC activity increase was observed in iso-
lated islets incubated with cytokines for 30 min to 4 h (Fig. 1B).
3.2. AC mRNA and protein expression are not regulated by cytokines
To investigate whether cytokine-induced AC activity increase is
caused by the change of AC transcription and/or translational level,
AC mRNA and protein levels in INS-1 cells or rat pancreatic islet
exposure to cytokines for different time points were determined
by semi-quantitative RT-PCR and western blot, respectively. The
results showed that cytokines treatment had no effect on ACmRNAFig. 1. Cytokines induce AC activity elevation in INS-1 cells and isolated rat islets.
INS-1 cells (A) or islets (B) were cultured in absence (control) or presence of a
cytokine mixture (5 ng/ml interleukin-1b, 10 ng/ml TNF-a, and 50 ng/ml inter-
feron-c, the same as below) for the indicated time periods. AC activity was assayed
by HPLC as described in methods. Results are expressed as the percentage of the
control. Values are mean ± S.D. of four separate experiments. *P < 0.05, **P < 0.01
compared with control.and protein level in INS-1 cells (Fig. 2A and B). Similar results were
observed in rat islets treated with cytokines (data not shown).3.3. Tyrosine phosphorylation of AC is responsible for cytokine-induced
AC activity elevation
In order to characterize the mechanism of AC activation induced
by cytokines, the tyrosine phosphorylation of AC was detected be-
cause previous studies found that AC activity was probably modu-
lated by phosphorylation of tyrosine kinase [8,18]. INS-1 cells were
treated with cytokines and the level of tyrosine phosphorylation in
AC was analyzed by immunoprecipitation. Our results showed that
tyrosine phosphorylation in AC increased sharply at 30 min after
stimulation (165.3 ± 31.6% of the control), reached maximal at
2 h (204.7 ± 35.0% of the control), and remained high level at 4 h
(151.2 ± 22.4% of the control) (Fig. 3A and B).
In order to further conﬁrm that AC activity increase induced by
cytokines is due to tyrosine phosphorylation in AC, genistein, a
speciﬁc tyrosine kinase inhibitor, was used. INS-1 cells were pre-
treated with 25 lM genistein for 1 h, followed by incubation with
cytokines for 2 h, and then the tyrosine phosphorylation and activ-
ity of AC in these cells were assayed by immunoprecipitation and
HPLC, respectively. Our results revealed that pretreatment of gen-
istein had no effect on the basal tyrosine phosphorylation and ba-
sal activity of AC, but cytokine-induced tyrosine phosphorylation
and AC activity elevation were abrogated by genistein (Fig. 4A
and B).3.4. Cytokine-induced cell growth inhibition is enhanced by inhibition
of AC
Previous reports showed that cytokines inhibit cell growth in
INS-1 cells [16,17]. In order to determine the effect of AC on cell
growth inhibition induced by cytokines in INS-1 cells, NOE, which
could potently inhibit AC [19], was used. The data showed that AC
activity in INS-1 cells was markedly inhibited by NOE when cyto-
kines were present or absent (Fig. 5A). MTT assay conﬁrmed that
treatment of INS-1 cells with cytokines for 18 h led to cell growthFig. 2. Cytokines do not affect AC protein and mRNA level in INS-1 cells. INS-1 cells
were cultured in absence (control) or presence of a cytokine mixture for the times
indicated, then western blot and semiquantitative PCR were done as described in
methods, (A) representative western blot was shown using anti-AC antibody or
anti-b-actin antibody. (B) Semiquantitative PCR was performed using the speciﬁc
primers for rat AC and GAPDH, and the representative RT-PCR result was shown
here.
Fig. 4. Inhibition of tyrosine phosphorylation blocks cytokine-induced AC activity
elevation. INS-1 cells were pretreated with 25 lM genistein for 1 h, then cultured in
absence or presence of a cytokine mixture for 2 h, the tyrosine phosphorylation in
AC was determined by immunoprecipitation and western blotting, the represen-
tative result was shown in (A). Meanwhile, the activity of AC was assayed by HPLC
as described in methods and the results are expressed as the percentage of the
control (B). Values are mean ± S.D. of three separate experiments. *P < 0.01
compared with untreated control; #P < 0.01.
Fig. 5. Inhibition of AC activity potentiates cytokine-induced cytotoxicity. INS-1
cells were pretreated with 100 lM NOE for 2 h, then incubated with a cytokine
mixture, (A) 2 h later, cells were collected and AC activity was assayed by HPLC.
Results are expressed as percentage of the control. Values are mean ± S.D. of three
separate experiments. *P < 0.01 compared with untreated control; #P < 0.01 com-
pared with cytokines alone. (B) 18 h later, cell viability was determined by MTT.
Results are expressed as the percentage of the control. Values are mean ± S.D. of
three separate experiments. *P < 0.05 compared with control; #P < 0.05 compared
with cytokines alone.
Fig. 3. Cytokines induce tyrosine phosphorylation of AC in INS-1 cells. INS-1 cells
were cultured in absence (control) or presence of a cytokine mixture for the
indicated time periods, and levels of tyrosine-phosphorylated AC and total AC were
analyzed by immunoprecipitation and western blot (A). Tyrosine phosphorylation
in AC were normalized to the expression of total AC, data are expressed as the
percentage of the control (B). Values are mean ± S.D. of three separate experiments
in triplicate. *P < 0.05 compared with control.
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cells). Co-treatment with NOE had a synergistic effect on INS-1 cell
growth (49.6 ± 6.1% cell viability compared to untreated control
cells) although this concentration of NOE had no effect on cell via-
bility (Fig. 5B).4. Discussion
The acute activation of AC in INS-1 cells and isolated rat islets
exposed to cytokines is the major ﬁnding in this study. This result,
taken together with our previous work on chronic activation of NC
in INS-1 cells treated by cytokines [13], revealed that cytokine
treatment leads to biphasic changes of ceramidase activity. This bi-
phasic ceramidase activation including acute AC activation and
chronic NC activation leads to early and late phases of sphingosine
elevation (data not shown). As we know, sphingosine is a substrate
of SPHK, so our data provide more evidence to explain cytokine-in-
duced biphasic regulation of SPHK and S1P level in islets and INS-1
cells [5]. The biphasic regulation of some key molecules in the
sphingolipid signaling pathway might be a universal phenomenon
under cytokine treatment. In fact, short-term stimulation of rat
mesangial cells with IL-1b/TNF-a leads to a rapid and transient
activation of neutral sphingomyelinase, a ceramide-generating en-
zyme [20], and a second delayed increase in neutral sphingomye-
linase activity occurs after hours of treatment [21].
This biphasic regulation of enzymes induced by cytokines in-
volved in sphingolipid signalling pathway happens through differ-
ent mechanisms. A late phase of SPHK activation induced by
cytokines is dependent on new protein synthesis [5]. Our previous
report [13] and the work of others [22] revealed that the chronic or
delayed activation of NC induced by cytokines was due to tran-
scriptional and translational activation of the gene. These data con-
ﬁrmed that late phase activation of these enzymes by cytokines
was regulated at both the mRNA and protein levels. However,
the early phase activation is modulated by a different mechanism.
For example, an early phase of SPHK activation induced by cyto-
kines is independent of new protein synthesis [5]. Putative phos-
phorylation mediated by protein kinase C may contribute to the
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that cytokine-induced AC activity elevation in rat b-cells was not
due to changes of AC mRNA and protein levels. The change of tyro-
sine phosphorylation in AC paralleled by the variation of enzyme
activity indicated that the increase in AC activity induced by cyto-
kines was due to tyrosine phosphorylation elevation in AC. This
concept was further conﬁrmed by genistein, which could potently
inhibit tyrosine phosphorylation, completely inhibited cytokine-
induced AC activation in INS-1 cells.
Another ﬁnding is that we ﬁrst detected AC activity in rat islets
(15.5 ± 2.3 pmol sphingosine min1 mg1 protein) and INS-1 cells
(26.3 ± 3.9 pmol sphingosine min1 mg1 protein). The activity of
AC in INS-1 cells is higher than that in isolated rat islets; the reason
might be that the latter is composed of at least three types of endo-
crine cells and other cell types. The study of the tissue distribution
of this ceramidase is very important to understand its functions. AC
is the ﬁrst identiﬁed [23,24] among ﬁve mammalian ceramidases
which have been cloned and biochemically characterized by now.
Human AC is involved in farber disease [24], but the tissue distri-
bution of human AC mRNA remains unknown. Mouse AC mRNA
is ubiquitously and highly expressed in kidney, lung, heart, and
brain but at relatively low levels in spleen, skeletal muscle, and tes-
tes [25]. Rat AC activity is higher in kidney than in other tissues
[26]. These results taken together with our work about AC activity
in rat pancreas would help us to understand the role of AC in b-cell
damage induced by cytokines and shed light on the mechanism of
diabetes.
Growing evidence revealed that ceramidases are critical in reg-
ulating not only the hydrolysis of ceramide but also in the genera-
tion of both sphingosine and S1P in cells [6,7]. AC involved in
ceramide hydrolysis and sphingosine/S1P generation could alter
the ratio of ceramide (sphingosine)/S1P and then control cellular
responses mediated by these bioactive lipids. In this study, we
found that NOE, a well-described inhibitor of AC, markedly en-
hanced cytokine-induced damage in INS-1 cells. This result sug-
gests that AC may potentially protect against cytokine
cytotoxicity. Some previous reports also conﬁrmed that AC affected
cell survival in response to various stressful stimuli. Strelow et al.
reported that overexpression of AC in mouse ﬁbroblast L929 cells
inhibited TNF-a-induced reduction in cell viability [27]. Hepatic
ischemia/reperfusion (I/R) could induce an early activation of AC,
whereas NOE potentiated I/R injury [28]. The mechanism by which
AC activation protects cells from stresses appears to involve the
regulation of the cellular ceramide/S1P ratio [6,7]. Ceramide has
been implicated in cell death and growth arrest following a myriad
of cellular stresses [29,30]. AC activation may result in a decrease
in the intracellular ceramide level and a concomitant increase in
S1P, which is believed to promote growth and survival [18,27].
So AC might affect the ‘‘ceramide/S1P rheostat” [6,7] and conse-
quently lead to cytoprotection.
It is worthy to note in this study that treatment with cytokines
caused activation of AC without new protein synthesis within 4 h,
whereas AC inhibition enhanced cytokine-induced cytotoxicity at
18 h. It appears that some time is required to accomplish the pro-
cess of cytokine stimulation? AC activation? ceramide
change? affecting cell growth. This is partly conﬁrmed by previ-
ous ﬁndings that the changes in intracellular ceramide levels in re-
sponse to stimuli occurred prior to the onset of the ﬁrst
biochemical signs of apoptosis or growth arrest [6,30], and hepatic
I/R could induce AC activation between 1 and 6 h, whereas NOE
signiﬁcantly enhanced I/R injury at 24 and 48 h after reperfusion
[28]. As we know, ceramide is a signaling molecule shown to be in-
volved in cell growth, differentiation, apoptosis, and other pro-
cesses. Whether other ceramide-related responses are induced or
not in the long-term treatment of cytokines will be studied in
our future work.In summary, there is constitutional AC activity in rat INS-1 cells
and isolated islets. Cytokines affect tyrosine phosphorylation in AC
and then upregulate its activity. Pharmacological inhibition of AC
potentiates cytotoxicity in INS-1 cells exposed to cytokines possi-
bly by affecting the ‘‘ceramide/S1P rheostat”.Acknowledgment
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